September 4, 2012

THE UMBRELLA CORPORATION
Plans $500 Million IPO

LOS ANGELES, September 4, 2012 – The Umbrella Corporation announced today that it has filed with the Global Exchange and Securities Commission for a proposed initial public offering of its common stock - ($500,000,000) shares at $25 per share. Shares are expected to begin trading on the Nasdaq Global Select Market on September 14, 2012 under the symbol "BLIFE.”

The altruistic mandate behind the IPO launch is to increase funding to allow for expansion of The Umbrella Corporation’s global infrastructure, with the goal of offering all shareholders a unique opportunity to be part of the corporation’s life changing developments. The IPO offering follows the phase one reorganization of company’s core communications including an extensive world recruitment tour in April, 2012 of its state-of-the-art Mobile Recruitment Center, which resulted in thousands of new recruits. This was followed by a phase two initiative, a global public relations outreach through its Facebook page in June 2012 resulting in an additional 300,000 new recruits. Phase three will see the launch of its revamped Umbrella Corporate website which will focus on the company’s corporate initiatives. (www.umbrellacorporation.net).

The Umbrella Corporation is involved in advanced research and development that includes clinical trials, scientific testing, and drug creation aimed at improving the health and condition of mankind and complete eradication of human suffering. In a groundbreaking move, as part of the stock purchase, shareholders will be sent free samples of the company’s latest breakthrough anti-aging drug.

Additionally, in this time of economic turmoil, The Umbrella Corporation will seek to shelter stockholders from the impending fiscal storm and provide coverage and stability for their families and themselves in a world made better by The Umbrella Corporation.

About The Umbrella Corporation

The Umbrella Corporation is proud to play an active part of the global solution, specifically in the areas of job creation and scientific advancement. The company is a biotech leader focused on the development of pharmaceuticals and technology designed for the betterment of all mankind. Our Business is Life Itself.

If you are interested in pursuing a journey of a lifetime with The Umbrella Corporation, please contact our specialized human resource managers.

Contact: The Umbrella Corporation

Website: www.umbrellacorporation.net

Facebook Page: https://www.facebook.com/umbrellacorp

The offering is being made through an underwriting group led by Global Private Bank Corporation and Biotech Giant Industries.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to this offering may be obtained from World Bank, 666 5th Avenue, Manhattan, NY 10022.

A registration statement relating to these securities has been filed with the Global Exchange and Securities Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Print & Download Certificate
  • Share
DeutschEnglish
EspañolCastellano
FrançaisItaliano
PortuguêsРусский
Polski한국어
繁体中文简化字